MonTa Biosciences ApS: Financial statements 2022
CVR: 36697016
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MonTa Biosciences ApS (CVR 36697016) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,756,938 and a net result of DKK -1,439,137 compared with DKK 1,406,263 the year before. That is a decrease of 17.5% compared with the year before. Equity in the 2022 report amounted to DKK 1,671,502. The solvency ratio was 3.4%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,756,938
- Profit/Loss
- DKK -1,439,137
- Equity
- DKK 1,671,502
- Total Assets
- DKK 49,154,101
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.8 mio. | -1.4 mio. | 1.7 mio. | 3 |
| 2021 | - | 2.1 mio. | 1.4 mio. | 3.1 mio. | 3 |
| 2020 | - | -13.3 mio. | -13.3 mio. | 1.7 mio. | 4 |
| 2019 | - | -7.1 mio. | -8.6 mio. | 15 mio. | 3 |
| 2018 | - | -178 t. | -760 t. | 686 t. | 1 |
Official annual report
Keep an eye on MonTa Biosciences ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 29, 2022, TLA-HOLDING 2010 ApS is registered as an owner of MonTa Biosciences ApS with an ownership share of 10%.
As of December 29, 2022, JENSEN BIOCONSULT ApS is registered as an owner of MonTa Biosciences ApS with an ownership share of 15%.
As of December 29, 2022, Consolidated Biosciences ApS is registered as an owner of MonTa Biosciences ApS with an ownership share of 50%.
MonTa Biosciences ApS has published its annual report for 2021. Gross profit came to DKK 2,130,489, and the net result was DKK 1,406,263.
About MonTa Biosciences ApS
MonTa Biosciences ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MonTa Biosciences IVS. The management consists of Simon Skjøde Jensen. The board consists of Lone Schøtt Kunøe (chair), Esper Boel, Sven Madsen and Søren Tulstrup. The company's owners include Jonas Rosager Henriksen, TLA-HOLDING 2010 ApS and JENSEN BIOCONSULT ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,811,082 and a net result of DKK -4,776,853 compared with DKK -3,920,572 the year before. Equity in the 2025 report amounted to DKK -10,304,549.